Melinta Therapeutics

BAXDELA

Manufacturer:

Melinta Therapeutics

Baxdela HCPCS:

C9462

HCPCS Code Descriptor:

Injection, delafloxacin, 1 mg

Category:

C Code

Baxdela NDCs:

70842-0102-03

Primary Type:

Antibiotic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Oral or Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

70842-0102-03

About Baxdela:

BAXDELA is an Antibiotic drug manufactured by Melinta Therapeutics and administered via the Oral or Intravenous route of administration. The C Code: C9462 is aligned to the drug BAXDELA.

ACCESS PRICING AND MORE BY REGISTERING

C9462 Added Date:

April 1, 2018

C9462 Effective Date:

January 1, 2022

C9462 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Baxdela billing and coding information.
Our team did not identify a source for Baxdela patient assistance information. Please reach out to our team if you feel that this is a mistake.
BAXDELA prescribing information can be found at the link below:
Information regarding BAXDELA’s side effects can be found at MedlinePlus